101 Views | 32 Downloads
Maya Fayfman, MD, Emory University School of Medicine, Division of Endocrinology, Metabolism & Lipids, 69 Jesse Hill Jr. Drive SE, Atlanta, GA 30303, Phone: (404) 778-1664, Fax: (404) 524-3052, maya.fayfman@emory.edu
Author Contributions. MF designed the study and wrote the first draft of the manuscript. MCS co-authored the study and critically reviewed the study design. CNA, RNW, and JLH designed the FGD script and carried out the FGD sessions. MMA performed data entry and review of the manuscript. RRJ, DCZ critically reviewed the manuscript. RRK and GEU critically reviewed the study design, manuscript and provided senior mentorship throughout the study. MF is the guarantor of this work and, as such, had full access to tall the data in the study and takes responsibility for the integrity of the data and the accuracy of the analysis.
The authors would like to thank Sierra Patterson for her efforts in patient recruitment and scheduling, Grady Memorial Hospital Diabetes Center and Transitions of Care clinic for allowing patient recruitment and providing space for conducting focus groups sessions.
No potential conflicts of interest relevant to this article are reported by the authors. GEU is partly supported by research grants from the NIH/NATS UL1 TR002378 from the Clinical and Translational Science Award program, and 1P30DK111024-01 from NIH and National Center for Research Resources. GEU has also received unrestricted support for research studies (to Emory University) from Novo Nordisk, Dexcom Inc, and Sanofi.
This work was supported in part by the Emory Medical Care Foundation (MF and MCS), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant number P30-DK-111024 (MCS), and the Atlanta Clinical and Translational Science Institute (UL1TR000454).
© 2020, Elsevier